Category: Product Launch
News about product and service launches
Contributing to advanced medical services including COVID-19 fight in Turkey- Delivering various high-technology medical imaging systems to a new large hospital –
Contributing to advanced medical services including COVID-19 fight in Turkey– Delivering various high-technology medical imaging systems to a new large hospital – Read more
Swift Biosciences Enables COVID-19 Surveillance With NGS of Low Titer SARS-CoV-2 Specimens
ANN ARBOR, Mich. – May 28, 2020 — Swift Biosciences, Inc., a leader in commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), has announced the release of its Swift Normalase™ Amplicon Panel (SNAP) SARS-CoV-2 kit. Targeting the full viral genome in a single tube reaction with a rapid 2-hour workflow, Swift’s... Read more
Miltenyi Biotec launches world’s first fully automated light sheet microscope
The UltraMicroscope Blaze enables 3D imaging of large or multiple cleared samples across scalesBERGISCH GLADBACH, May 28, 2020 – Miltenyi Biotec today announces the UltraMicroscope Blaze. With cutting-edge optics, it is the world’s first and only fully automated light sheet microscope. The new instrument enables users to image an entire mouse or multiple samples at subcellular... Read more
Thermo Fisher Scientific to Showcase New Mass Spectrometry Systems and Software During Virtual ASMS Event
Thermo Fisher Scientific to Showcase New Mass Spectrometry Systems and Software During Virtual ASMS Event Digital programs will enable scientists to broaden mass spectrometry-based research, from proteomics and biotherapeutics to clinical applications WALTHAM, Mass., May 27, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will provide online programming and... Read more
Product Launch: CytoSMART Technologies announces the launch of the CytoSMART Lux2 Duo Kit
Caption: CytoSMART Lux2 Duo Kit offers side-by-side comparisons between cell cultures. To download this image, click here. 26 May 2020, Eindhoven, The Netherlands – Life Science Newswire – CytoSMART Technologies today announced the launch of a new live-cell imaging system. The CytoSMART Lux2 Duo Kit offers a straightforward, cost-effective solution for researchers carrying out immediate side-by-side comparisons between cell cultures.... Read more
Leica Biosystems and Bio-Techne Announce European Launch of the CE-IVD RNAscope in Situ Hybridization Detection Kit
MAY 26, 2020 The CE-IVD marked system will enable diagnostic pathologists with new applications MINNEAPOLIS, May 26, 2020 /PRNewswire/ — Bio-Techne (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities and Leica Biosystems, a global leader in workflow solutions and automation, are proud to announce... Read more
New, Versatile High-Resolution Mass Spectrometer Expands Market-leading Thermo Scientific Orbitrap Platform
Thermo Scientific Orbitrap Exploris 240 mass spectrometer drives discovery and identification with quantitative precision and accuracy to meet customers’ specific analytical requirements Read more
Oxford Nanopore Technologies announces advanced development of LamPORE, for rapid, highly scalable, low-cost COVID-19 detection
Fri 22nd May 2020 LamPORE is designed for use in both high-throughput labs or decentralised locations- Oxford Nanopore Technologies is in advanced development of a new generation of end-to-end test (assay) for the detection of SARS-CoV-2, the virus that causes COVID-19. The LamPORE assay is designed to be rapid, low cost, and scalable to cater... Read more
New longer-term data reinforce safety of Roche’s satralizumab in adults and adolescents with neuromyelitis optica spectrum disorder
Pooled data from two pivotal Phase III open-label extension (OLE) studies show satralizumab was well-tolerated as a monotherapy or in combination with baseline immunosuppressive therapy in people with neuromyelitis optica spectrum disorder (NMOSD) Adolescents treated with the same dosing and frequency demonstrated a benefit-risk profile generally consistent with the adult population Current dosing achieved sustained... Read more